Representative Julie Johnson (D-Texas) recently sold shares of Colgate-Palmolive Company NYSE: CL. In a filing disclosed on October 07th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on September 25th. The trade occurred in the Representative's "MERRILL LYNCH LONG TERM GROWTH" account.
Representative Julie Johnson also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Ameren NYSE: AEE on 9/25/2025.
- Sold $1,001 - $15,000 in shares of WEC Energy Group NYSE: WEC on 9/25/2025.
- Sold $1,001 - $15,000 in shares of Equinix NASDAQ: EQIX on 9/25/2025.
- Sold $1,001 - $15,000 in shares of A. O. Smith NYSE: AOS on 9/25/2025.
- Sold $1,001 - $15,000 in shares of Honeywell International NASDAQ: HON on 9/25/2025.
- Sold $1,001 - $15,000 in shares of McCormick & Company, Incorporated NYSE: MKC on 9/25/2025.
- Sold $1,001 - $15,000 in shares of Monster Beverage NASDAQ: MNST on 9/25/2025.
- Sold $1,001 - $15,000 in shares of Molson Coors Beverage NYSE: TAP on 9/25/2025.
- Sold $1,001 - $15,000 in shares of LyondellBasell Industries NYSE: LYB on 9/25/2025.
- Sold $1,001 - $15,000 in shares of United Dominion Realty Trust NYSE: UDR on 9/25/2025.
Colgate-Palmolive Trading Down 1.5%
CL opened at $77.96 on Thursday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a fifty-two week low of $77.09 and a fifty-two week high of $102.61. The firm has a market capitalization of $63.01 billion, a PE ratio of 21.90, a P/E/G ratio of 4.11 and a beta of 0.34. The company's 50-day moving average is $82.79 and its 200 day moving average is $88.08.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The firm's revenue was up 1.0% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive's dividend payout ratio is currently 58.43%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CL. Norges Bank purchased a new position in Colgate-Palmolive in the second quarter valued at about $960,390,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Colgate-Palmolive by 18.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company's stock valued at $3,186,651,000 after buying an additional 5,269,140 shares in the last quarter. Schroder Investment Management Group grew its stake in Colgate-Palmolive by 242.3% in the 2nd quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company's stock valued at $483,962,000 after buying an additional 3,768,784 shares in the last quarter. Nuveen LLC purchased a new position in Colgate-Palmolive in the 1st quarter valued at approximately $217,593,000. Finally, Goldman Sachs Group Inc. grew its stake in Colgate-Palmolive by 34.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company's stock valued at $747,762,000 after buying an additional 2,045,191 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the stock. The Goldman Sachs Group lowered their target price on shares of Colgate-Palmolive from $106.00 to $91.00 and set a "buy" rating on the stock in a report on Thursday, October 2nd. Citigroup cut their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Morgan Stanley cut their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Piper Sandler began coverage on shares of Colgate-Palmolive in a report on Friday, October 3rd. They set a "neutral" rating and a $84.00 price target on the stock. Finally, UBS Group cut their price target on shares of Colgate-Palmolive from $99.00 to $92.00 and set a "buy" rating on the stock in a report on Wednesday. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $93.23.
Get Our Latest Research Report on Colgate-Palmolive
About Representative Johnson
Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024.
Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.
Colgate-Palmolive Company Profile
(
Get Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.